Product Code: TMRGL45147
Heart Pumps Market - Scope of Report
TMR's report on the global heart pumps market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global heart pumps market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global heart pumps market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the heart pumps market.
Market Snapshot |
Market Value in 2022 | US$ 2.7 Bn |
Market Value in 2031 | US$ 12.3 Bn |
CAGR | 18.3% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global heart pumps market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global heart pumps market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global heart pumps market.
The report delves into the competitive landscape of the global heart pumps market. Key players operating in the global heart pumps market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global heart pumps market profiled in this report.
Key Questions Answered in Global heart pumps Market Report:
- What is the sales/revenue generated by heart pumps across all regions during the forecast period?
- What are the opportunities in the global heart pumps market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Heart Pumps Market - Research Objectives and Research Approach
The comprehensive report on the global heart pumps market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global heart pumps market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global heart pumps market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Heart Pumps Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Heart Pumps Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Product/Brand Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry
6. Global Heart Pumps Market Analysis and Forecast, by Product
- 6.1. Introduction and Definitions
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Intra-aortic Balloon Pumps
- 6.3.2. Ventricular Assist Devices
- 6.3.2.1. Left Ventricle Assist Devices (LVAD)
- 6.3.2.2. Right Ventricle Assist Devices (RVAD)
- 6.3.2.3. Biventricular Assist Devices (BVAD)
- 6.3.2.4. Others
- 6.3.3. Total Artificial Heart
- 6.4. Market Attractiveness, by Product
7. Global Heart Pumps Market Analysis and Forecast, by Flow Regime
- 7.1. Introduction and Definitions
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Flow Regime, 2017-2031
- 7.3.1. Centrifugal Flow Pump (CFP)
- 7.3.2. Axial Flow Pump (AFP)
- 7.3.3. Mixed Flow Pump (MFP)
- 7.4. Market Attractiveness, by Flow Regime
8. Global Heart Pumps Market Analysis and Forecast, By Therapy
- 8.1. Introduction and Definitions
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, By Therapy, 2017-2031
- 8.3.1. Bridge-to-Candidacy (BTC)
- 8.3.2. Bridge-to-Transplant (BTT)
- 8.4. Market Attractiveness, By Therapy
9. Global Heart Pumps Market Analysis and Forecast, by Location
- 9.1. Introduction and Definitions
- 9.2. Key Findings/Developments
- 9.3. Market Value Forecast, by Location, 2017-2031
- 9.3.1. Implantable Heart Pump Devices
- 9.3.2. Extracorporeal Heart Pump Devices
- 9.4. Market Attractiveness, by Location
10. Global Heart Pumps Market Analysis and Forecast, by End-user
- 10.1. Introduction and Definitions
- 10.2. Key Findings/Developments
- 10.3. Market Value Forecast, by End-user, 2017-2031
- 10.3.1. Hospitals
- 10.3.2. Ambulatory Surgical Centers
- 10.3.3. Specialty Clinics
- 10.3.4. Others
- 10.4. Market Attractiveness, by End-user
11. Global Heart Pumps Market Analysis and Forecast, by Region
- 11.1. Key Findings
- 11.2. Market Value Forecast, by Region, 2017-2031
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
- 11.3. Market Attractiveness, by Region
12. North America Heart Pumps Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Intra-aortic Balloon Pumps
- 12.2.2. Ventricular Assist Devices
- 12.2.2.1. Left Ventricle Assist Devices (LVAD)
- 12.2.2.2. Right Ventricle Assist Devices (RVAD)
- 12.2.2.3. Biventricular Assist Devices (BVAD)
- 12.2.2.4. Others
- 12.2.3. Total Artificial Heart
- 12.3. Market Attractiveness, by Product
- 12.4. Market Value Forecast, by Flow Regime, 2017-2031
- 12.4.1. Centrifugal Flow Pump (CFP)
- 12.4.2. Axial Flow Pump (AFP)
- 12.4.3. Mixed Flow Pump (MFP)
- 12.5. Market Attractiveness, by Flow Regime
- 12.6. Market Value Forecast, By Therapy, 2017-2031
- 12.6.1. Bridge-to-Candidacy (BTC)
- 12.6.2. Bridge-to-Transplant (BTT)
- 12.7. Market Attractiveness, By Therapy
- 12.8. Market Value Forecast, by Location, 2017-2031
- 12.8.1. Implantable Heart Pump Devices
- 12.8.2. Extracorporeal Heart Pump Devices
- 12.9. Market Attractiveness, by Location
- 12.10. Market Value Forecast, by End-user, 2017-2031
- 12.10.1. Hospitals
- 12.10.2. Ambulatory Surgical Centers
- 12.10.3. Specialty Clinics
- 12.10.4. Others
- 12.11. Market Attractiveness, by End-user
- 12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.12.1. U.S.
- 12.12.2. Canada
- 12.13. Market Attractiveness Analysis
- 12.13.1. By Product
- 12.13.2. By Flow Regime
- 12.13.3. By Therapy
- 12.13.4. By Location
- 12.13.5. By End-user
- 12.13.6. By Country
13. Europe Heart Pumps Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Intra-aortic Balloon Pumps
- 13.2.2. Ventricular Assist Devices
- 13.2.2.1. Left Ventricle Assist Devices (LVAD)
- 13.2.2.2. Right Ventricle Assist Devices (RVAD)
- 13.2.2.3. Biventricular Assist Devices (BVAD)
- 13.2.2.4. Others
- 13.2.3. Total Artificial Heart
- 13.3. Market Attractiveness, by Product
- 13.4. Market Value Forecast, by Flow Regime, 2017-2031
- 13.4.1. Centrifugal Flow Pump (CFP)
- 13.4.2. Axial Flow Pump (AFP)
- 13.4.3. Mixed Flow Pump (MFP)
- 13.5. Market Attractiveness, by Flow Regime
- 13.6. Market Value Forecast, By Therapy, 2017-2031
- 13.6.1. Bridge-to-Candidacy (BTC)
- 13.6.2. Bridge-to-Transplant (BTT)
- 13.7. Market Attractiveness, By Therapy
- 13.8. Market Value Forecast, by Location, 2017-2031
- 13.8.1. Implantable Heart Pump Devices
- 13.8.2. Extracorporeal Heart Pump Devices
- 13.9. Market Attractiveness, by Location
- 13.10. Market Value Forecast, by End-user, 2017-2031
- 13.10.1. Hospitals
- 13.10.2. Ambulatory Surgical Centers
- 13.10.3. Specialty Clinics
- 13.10.4. Others
- 13.11. Market Attractiveness, by End-user
- 13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.12.1. Germany
- 13.12.2. U.K.
- 13.12.3. France
- 13.12.4. Italy
- 13.12.5. Spain
- 13.12.6. Rest of Europe
- 13.13. Market Attractiveness Analysis
- 13.13.1. By Product
- 13.13.2. By Flow Regime
- 13.13.3. By Therapy
- 13.13.4. By Location
- 13.13.5. By End-user
- 13.13.6. By Country/Sub-region
14. Asia Pacific Heart Pumps Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Intra-aortic Balloon Pumps
- 14.2.2. Ventricular Assist Devices
- 14.2.2.1. Left Ventricle Assist Devices (LVAD)
- 14.2.2.2. Right Ventricle Assist Devices (RVAD)
- 14.2.2.3. Biventricular Assist Devices (BVAD)
- 14.2.2.4. Others
- 14.2.3. Total Artificial Heart
- 14.3. Market Attractiveness, by Product
- 14.4. Market Value Forecast, by Flow Regime, 2017-2031
- 14.4.1. Centrifugal Flow Pump (CFP)
- 14.4.2. Axial Flow Pump (AFP)
- 14.4.3. Mixed Flow Pump (MFP)
- 14.5. Market Attractiveness, by Flow Regime
- 14.6. Market Value Forecast, By Therapy, 2017-2031
- 14.6.1. Bridge-to-Candidacy (BTC)
- 14.6.2. Bridge-to-Transplant (BTT)
- 14.7. Market Attractiveness, By Therapy
- 14.8. Market Value Forecast, by Location, 2017-2031
- 14.8.1. Implantable Heart Pump Devices
- 14.8.2. Extracorporeal Heart Pump Devices
- 14.9. Market Attractiveness, by Location
- 14.10. Market Value Forecast, by End-user, 2017-2031
- 14.10.1. Hospitals
- 14.10.2. Ambulatory Surgical Centers
- 14.10.3. Specialty Clinics
- 14.10.4. Others
- 14.11. Market Attractiveness, by End-user
- 14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.12.1. China
- 14.12.2. Japan
- 14.12.3. India
- 14.12.4. Australia & New Zealand
- 14.12.5. Rest of Asia Pacific
- 14.13. Market Attractiveness Analysis
- 14.13.1. By Product
- 14.13.2. By Flow Regime
- 14.13.3. By Therapy
- 14.13.4. By Location
- 14.13.5. By End-user
- 14.13.6. By Country/Sub-region
15. Latin America Heart Pumps Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Product, 2017-2031
- 15.2.1. Intra-aortic Balloon Pumps
- 15.2.2. Ventricular Assist Devices
- 15.2.2.1. Left Ventricle Assist Devices (LVAD)
- 15.2.2.2. Right Ventricle Assist Devices (RVAD)
- 15.2.2.3. Biventricular Assist Devices (BVAD)
- 15.2.2.4. Others
- 15.2.3. Total Artificial Heart
- 15.3. Market Attractiveness, by Product
- 15.4. Market Value Forecast, by Flow Regime, 2017-2031
- 15.4.1. Centrifugal Flow Pump (CFP)
- 15.4.2. Axial Flow Pump (AFP)
- 15.4.3. Mixed Flow Pump (MFP)
- 15.5. Market Attractiveness, by Flow Regime
- 15.6. Market Value Forecast, By Therapy, 2017-2031
- 15.6.1. Bridge-to-Candidacy (BTC)
- 15.6.2. Bridge-to-Transplant (BTT)
- 15.7. Market Attractiveness, By Therapy
- 15.8. Market Value Forecast, by Location, 2017-2031
- 15.8.1. Implantable Heart Pump Devices
- 15.8.2. Extracorporeal Heart Pump Devices
- 15.9. Market Attractiveness, by Location
- 15.10. Market Value Forecast, by End-user, 2017-2031
- 15.10.1. Hospitals
- 15.10.2. Ambulatory Surgical Centers
- 15.10.3. Specialty Clinics
- 15.10.4. Others
- 15.11. Market Attractiveness, by End-user
- 15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.12.1. Brazil
- 15.12.2. Mexico
- 15.12.3. Rest of Latin America
- 15.13. Market Attractiveness Analysis
- 15.13.1. By Product
- 15.13.2. By Flow Regime
- 15.13.3. By Therapy
- 15.13.4. By Location
- 15.13.5. By End-user
- 15.13.6. By Country/Sub-region
16. Middle East & Africa Heart Pumps Market Analysis and Forecast
- 16.1. Introduction
- 16.2. Market Value Forecast, by Product, 2017-2031
- 16.2.1. Intra-aortic Balloon Pumps
- 16.2.2. Ventricular Assist Devices
- 16.2.2.1. Left Ventricle Assist Devices (LVAD)
- 16.2.2.2. Right Ventricle Assist Devices (RVAD)
- 16.2.2.3. Biventricular Assist Devices (BVAD)
- 16.2.2.4. Others
- 16.2.3. Total Artificial Heart
- 16.3. Market Attractiveness, by Product
- 16.4. Market Value Forecast, by Flow Regime, 2017-2031
- 16.4.1. Centrifugal Flow Pump (CFP)
- 16.4.2. Axial Flow Pump (AFP)
- 16.4.3. Mixed Flow Pump (MFP)
- 16.5. Market Attractiveness, by Flow Regime
- 16.6. Market Value Forecast, By Therapy, 2017-2031
- 16.6.1. Bridge-to-Candidacy (BTC)
- 16.6.2. Bridge-to-Transplant (BTT)
- 16.7. Market Attractiveness, By Therapy
- 16.8. Market Value Forecast, by Location, 2017-2031
- 16.8.1. Implantable Heart Pump Devices
- 16.8.2. Extracorporeal Heart Pump Devices
- 16.9. Market Attractiveness, by Location
- 16.10. Market Value Forecast, by End-user, 2017-2031
- 16.10.1. Hospitals
- 16.10.2. Ambulatory Surgical Centers
- 16.10.3. Specialty Clinics
- 16.10.4. Others
- 16.11. Market Attractiveness, by End-user
- 16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 16.12.1. GCC Countries
- 16.12.2. South Africa
- 16.12.3. Rest of Middle East & Africa
- 16.13. Market Attractiveness Analysis
- 16.13.1. By Product
- 16.13.2. By Flow Regime
- 16.13.3. By Therapy
- 16.13.4. By Location
- 16.13.5. By End-user
- 16.13.6. By Country/Sub-region
17. Competition Landscape
- 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
- 17.2. Market Share Analysis, by Company (2022)
- 17.3. Company Profiles
- 17.3.1. SynCardia Systems, LLC
- 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.1.2. Product Portfolio
- 17.3.1.3. Financial Overview
- 17.3.1.4. SWOT Analysis
- 17.3.1.5. Strategic Overview
- 17.3.2. Berlin Heart GmbH
- 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.2.2. Product Portfolio
- 17.3.2.3. Financial Overview
- 17.3.2.4. SWOT Analysis
- 17.3.2.5. Strategic Overview
- 17.3.3. Jarvik Heart Inc.
- 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.3.2. Product Portfolio
- 17.3.3.3. Financial Overview
- 17.3.3.4. SWOT Analysis
- 17.3.3.5. Strategic Overview
- 17.3.4. Calon Cardio-Technology Ltd.
- 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.4.2. Product Portfolio
- 17.3.4.3. Financial Overview
- 17.3.4.4. SWOT Analysis
- 17.3.4.5. Strategic Overview
- 17.3.5. Teleflex Incorporated
- 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.5.2. Product Portfolio
- 17.3.5.3. Financial Overview
- 17.3.5.4. SWOT Analysis
- 17.3.5.5. Strategic Overview
- 17.3.6. Abbott Laboratories
- 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.6.2. Product Portfolio
- 17.3.6.3. Financial Overview
- 17.3.6.4. SWOT Analysis
- 17.3.6.5. Strategic Overview
- 17.3.7. Medtronic plc
- 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 17.3.7.2. Product Portfolio
- 17.3.7.3. Financial Overview
- 17.3.7.4. SWOT Analysis
- 17.3.7.5. Strategic Overview